Introduction
============

Voltage-dependent calcium channels (Ca~v~)[^3^](#FN4){ref-type="fn"} constitute a major pathway for the entry of calcium into excitable cells. There are three main classes of Ca~v~ channels (Ca~v~1--3), which expression varies according to tissue and cell type ([@B1]). The main pore-forming Ca~v~α~1~ subunit carries the main biophysical and pharmacological properties of the channel. Ca~v~1α~1~ and Ca~v~2α~1~ subunits are associated with accessory subunits Ca~v~β and Ca~v~α~2~δ. Both Ca~v~β and Ca~v~α~2~δ play a dual role in regulating both the biophysical properties and trafficking of Ca~v~ channels ([@B2][@B3][@B4]). In contrast, Ca~v~3 channels are thought to be solely constituted of the pore-forming Ca~v~α~1~ subunit ([@B1]).

In addition to their voltage dependence, the channels are regulated by signaling pathways. Previously, we have shown that phosphorylation of Ca~v~β~2~ regulates the expression of Ca~v~1 and Ca~v~2 channels at the plasma membrane ([@B4]). A growing number of studies show that, like phosphorylation, ubiquitylation plays a major role in regulating the surface density of membrane proteins. In many cases, ubiquitylation acts as a signal for endocytosis of plasma membrane proteins, which are subsequently degraded by the lysosome or the proteasome ([@B5]). Ubiquitylation also occurs at the exit of the endoplasmice reticulum (ER) ([@B5]) and the trans-Golgi network (TGN) ([@B6], [@B7]). One family of ubiquitin ligases, Nedd4 ([@B8]), has been shown to ubiquitylate and down-regulate a wide range of ion channels, including KCNQ1 potassium ([@B9]) and Na~v~1.5 sodium channels ([@B10], [@B11]) in heterologous expression systems. In native tissues, ENaC epithelial sodium channels ([@B12]), K~v~1.3 ([@B13]), and ClC-5 channels ([@B14]) have also been shown to be down-regulated by Nedd4-like enzymes. However, the potential role of Nedd4 ubiquitin ligases on Ca~v~ channels has not yet been examined.

Our study focuses on dihydropyridine-sensitive Ca~v~1.2 channels, which are ubiquitously expressed in excitable cells, and are the predominant isoform expressed in the cardiovascular system. We used mammalian cell lines to investigate whether Nedd4 ligases regulate Ca~v~1.2α~1~ channels expressed together with Ca~v~β~2~ and Ca~v~α~2~δ-1. Of the three family members tested (Nedd4-1, Nedd4-2, and WWP2), only Nedd4-1 was found to alter Ca~v~ whole-cell currents. Overexpressing Nedd4-1 reduced both Ca~v~ currents and the surface expression of Ca~v~1.2α1. The Nedd4-1-induced down-regulation of Ca~v~ channels at the plasma membrane was associated with a decrease in the total expression of Ca~v~1.2α1, Ca~v~β~2~, and Ca~v~α~2~δ-1. Immunoprecipitation and pulldown assays of ubiquitylated proteins failed to show any increase in the ubiquitylation level of either Ca~v~ subunit, suggesting that the ubiquitin ligase acts indirectly on the channel. Evidence obtained using a variety of tools, interfering with either the internalisation or the forward trafficking of membrane proteins, suggests that Nedd4-1 promotes the targeting of Ca~v~ channels directly from the ER-Golgi network toward the proteasomal and lysosomal compartments. Finally, Ca~v~1.2α1/α~2~δ-1 (without Ca~v~β subunit) channels failed to be regulated by Nedd4-1, suggesting that the accessory Ca~v~β subunit is essential for the Nedd4-1-induced degradation of newly synthesized Ca~v~ channels.

EXPERIMENTAL PROCEDURES
=======================

### 

#### cDNA Constructs

Rabbit Ca~v~1.2α1 (cP15381.1), Ca~v~β~2~ (P54288), and Ca~v~α~2~δ-1 (P13806) cDNAs, inserted into pCARDHE, pBH17, and pCA1S respectively, were gifts from Dr. G. S. Pitt (Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC). Rabbit Ca~v~2.2α1 (D14157), Ca~v~3.2α1, rat Ca~v~β~1~ (X61394), β~3~ (M88751), and β~4~ (L02315) cDNAs inserted into pMT~2~ were gifts from professor A. C. Dolphin (Department of Neuroscience, Physiology, and Pharmacology, University College London, London, UK). Human Nedd4-1 (KIAA0093) and Nedd4-2 (KIAA0439) cDNA subcloned into pcDNA3.1 (Invitrogen) were gifts from Dr. T. Nagase (Kazusa Institute, Kazusa, Japan). Human WWP2 cDNA (U96114) was amplified by PCR from a human heart cDNA library (Matchmaker, NT 91-2769; Clontech, Basel, Switzerland), cloned into EcoRI-digested pcDNA3.1. CD8 cDNA was subcloned into EBOpcD-Leu2. Human dynamin I wild-type and mutant (K44R) cDNAs inserted into pcDNA3.1 were gifts from Pr. O. Staub (Department of Pharmacology and Toxicology, Lausanne, Switzerland). A GST fusion of the ubiquitin binding proteasomal subunit S5A (GST-S5A) was obtained from a S5A cDNA cloned into pGEX-4T1 (Amersham Biosciences, Otelfingen, Switzerland). Ca~v~β~2~Y221A and Nedd4-1C867S mutant were generated using the QuikChange XL II mutagenesis kit (Stratagene) and verified by sequencing. Myc-Nedd4-1 was generated by PCR, using 5′-GTC CAT AAG CTT GCC ACC ATG GAG CAG AAG TTG ATT AGC GAG GAG GAT TTG GCA ACT TGC GCG GTG GAG GTG-3′ and 5′-GTC CAT CTC GAG CTA ATC AAC TCC ATC AAA-3′ primers.

#### Transfections

For electrophysiology experiments, tsA-201 cells were transiently transfected with 7.5 μl of transfection reagent FuGENE 6® (Roche Diagnostics) and 0.3 μg cDNA of each Ca~v~ channel subunit (Ca~v~1.2α1, Ca~v~β, and Ca~v~α~2~δ-1; ratio 1:1:1) together with 1.0 μg of either Nedd4, WWP2, or dynamin constructs, per 25 cm^2^ flask. Empty pcDNA3.1 vector was used as a control. In addition, 0.5 μg of cDNA encoding CD8 antigen was added to all transfections as a reporter gene. At 24 h post-transfection, cells were split at low density (3% of one 25 cm^2^ flask per dish). Anti-CD8 beads (Dynal®, Oslo, Norway) were used to identify transfected cells. For biochemistry experiments, 10-cm dishes of HEK-293 cells were transfected using 10 μg of cDNAs and 30 μl of Lipofectamine LTX® (Invitrogen). The ratio of the different constructs was similar as for the patch clamp experiments. Cells were used 48 h after transfection.

#### Electrophysiology

Whole-cell currents were measured at room temperature (22--23 °C) using an Axopatch200B amplifier (Axon Instruments, Union City, CA). The internal pipette solution was composed of the following: 60 m[m]{.smallcaps} CsCl, 70 m[m]{.smallcaps} cesium-aspartate, 1 m[m]{.smallcaps} MgCl~2~, 10 m[m]{.smallcaps} HEPES, 11 m[m]{.smallcaps} EGTA, and 5 m[m]{.smallcaps} Mg-ATP, pH 7.2, with CsOH. The external solution contained the following: 130 m[m]{.smallcaps} NaCl, 5.6 m[m]{.smallcaps} KCl, 1--20 m[m]{.smallcaps} BaCl~2~, 1 m[m]{.smallcaps} MgCl~2~, 10 m[m]{.smallcaps} HEPES, and 11 m[m d]{.smallcaps}-glucose, pH 7.4, with NaOH. Current records are shown after leak and capacitance current subtraction (P/4 protocol). Data were analyzed using pClamp (version 9.2, Axon Instruments, Union City, California) and Origin (version 7.5, OriginLab® corporation, Northampton, MD) software. Barium current densities in picoamperes/picofarads (pA/pF) were calculated by dividing the peak current by the cell capacitance. The *I-V* relationship (*IV*) was fitted with the following equation, *y* = (*G*~max~(*Vh* − *V*~rev,Ca~))/(1 + exp((*Vh* − *V*~50~)/*k*)), in which *y* is the normalized peak current (pA/pF) at a given holding potential (*Vh*), *V*~50~ is the voltage at which half of the channels are activated, *k* is the slope factor, and *G*~max~ is the maximum conductance. Activation curves and steady-state inactivation curves were fitted with the following single Boltzmann equation, *y* = 1/(1 + exp((*Vh* − *V*~50~)/*k*)), in which *y* is the normalized conductance (activation) or peak current (steady-state inactivation) at a given holding potential (*Vh*), *V*~50~ is the voltage at which half of the channels are activated (*V*~50,act~) or inactivated (*V*~50,inact~) respectively, and *k* is the slope factor.

#### Western Blots

10-cm HEK-293 cells dishes or whole C57BL/6 mouse heart mechanically dissociated were lysed in 1.0 ml of lysis buffer (50 m[m]{.smallcaps} HEPES, pH 7.4, 150 m[m]{.smallcaps} NaCl, 10% glycerol, 1% Triton, 1 m[m]{.smallcaps} EGTA supplemented with 10 m[m]{.smallcaps} *N*-ethyl maleimide, and protease inhibitors). Soluble fractions were recovered in supernatants after 15 min of centrifugation at 13,000 × *g* at 4 °C.

#### Immunoprecipitations

One mg of HEK-293 cells or C57BL/6 mouse heart lysate were incubated for 2 h at 4 °C with appropriate antibody previously linked to Dynabeads A (Invitrogen) according to the manufacturer\'s instructions. Negative control for mouse heart immunoprecipitation was done with unspecific rabbit antibodies (Santa Cruz Biotechnology, Santa Cruz, CA).

#### Pulldown Assays

One mg of HEK-293 cell lysate was added to either 50 μg of GST-S5A beads or 50 μg of beads from the ubiQapture kit (Enzo Life Science, Lausanne, Switzerland) and incubated for 2 h at 4 °C. Precipitated proteins were eluted with sample buffer (Invitrogen).

#### Surface Biotinylation Assays

Cells were treated for 30 min at 4 °C with 4 ml of biotin per 10-cm dish (1 mg/ml; EZ link sulfo-NHS-SS-biotin; Pierce), washed three times with cold PBS containing 200 m[m]{.smallcaps} glycine, and lysed with 1-ml/dish of lysis buffer. Fifty μl of streptavidin Sepharose beads (GE Healthcare Europe, Glattbrugg, Switzerland) were added to 1 mg of HEK-293 cell lysate and incubated 2 h on a wheel at 4 °C. The beads were washed five times with lysis buffer and resuspended in sample buffer (Invitrogen). Eluted proteins were analyzed by Western blot.

#### Antibodies

Anti-ubiquitin monoclonal antibody FK2 (Enzo Life Science, Lausanne, Switzerland) was used at a dilution of 1:500. Antibodies against Ca~v~1.2α1 (ACC003; Alomone, Jerusalem, Israel) and Ca~v~β~2~ (ab54920; Abcam, Cambridge, UK) were used at a dilution 1:200 and Ca~v~α~2~δ-1 (ab2864; Abcam) was used at a dilution of 1:1000. Nedd4 antibody, used at a dilution of 1:1000, was a gift from professor O.Staub (Department of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland). Monoclonal antibodies raised against actin and Myc were purchased from Sigma-Aldrich (Sigma-Aldrich Chemie, Postfach, Switzerland) and used at a dilution of 1:2000.

#### Drugs

Monodansylcadaverine (MDC), brefeldin A (BFA), MG132, and chloroquine diphosphate were purchased from Sigma-Aldrich (Sigma-Aldrich, Dorset, UK). Chloroquine was dissolved in water. MDC, BFA, and MG132 were dissolved in DMSO. DMSO did not exceed 0.1% in the final solution.

#### Statistical Analysis

Data are presented as means ± standard error of the mean. Unpaired, two-tailed Student\'s *t* tests or one-way analysis of variance with a Bonferroni post-test were used to compare the means; *p* \< 0.05 was considered significant.

RESULTS
=======

### 

#### Nedd4-1 Down-regulates Ca~v~1.2 Channels

We expressed Ca~v~1.2α1/β~2~/α~2~δ-1 channels together with Nedd4-1, Nedd4-2, or their close relative WWP2. [Fig. 1](#F1){ref-type="fig"}*A* shows that Nedd4-1 dramatically reduced Ca~v~ currents by 67 ± 10% (*n* = 7), whereas neither Nedd4-2 nor WWP2 showed significant effects (+8 ± 47%; *n* = 6 and −13 ± 34%; *n* = 7). Conversely, expression of a catalytically inactive Nedd4-1 mutant (Nedd4-1C867S) significantly increased Ca~v~1.2 current densities by 90 ± 33% (*n* = 9; [Fig. 1](#F1){ref-type="fig"}, *A* and *B*), suggesting that Ca~v~1.2 channels may be constitutively regulated by an endogenous pool of Nedd4-1. Nedd4-1 also induced a minor shift of the current-voltage relationship and steady-state inactivation curves ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). Interestingly, it is known that in the absence of Ca~v~β, Ca~v~ currents are also dramatically reduced, and their biophysical parameters are shifted in the same direction as with Nedd4-1, although the amplitude of the shifts is significantly more pronounced ([@B2]) ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). To examine whether Nedd4-1 may reduce the current by disrupting the interaction of Ca~v~β with the pore of the channel, we performed co-immunoprecipitation experiments ([supplemental Fig. 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). These showed that the same proportion of Ca~v~β~2~ was associated with Ca~v~1.2α1 in control and Nedd4-1-transfected cells. Hence, there is no evidence that Nedd4-1 interferes with the binding of Ca~v~β to the pore subunit of the channel.

![**Nedd4-1 down-regulates Ca~v~1.2 channels.** *A*, representative whole-cell current traces. *B*, *I-V* relationships recorded from tsA-201 cells transfected with Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 channels alone (*Control*, ○) or together with either Nedd4-1 (■), Nedd4-2 (●), WWP2 (▲), or the catalytically inactive mutant Nedd4-1C867S (♦). The number of cells recorded is indicated in *parentheses*. \*, *p* \< 0.05 when compared with control cells transfected with Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 channels alone. *C* and *D*, surface biotinylation assays were performed in control, Nedd4-1- and Nedd4-1C867S-transfected HEK-293 cells. Western blots (*WB*) showing Ca~v~ channels detected in the biotinylated fraction (*C*) and corresponding whole-cell lysates (*D*). *E*, bar graphs illustrating the down-regulation of Ca~v~1.2α1, Ca~v~β~2~, and Ca~v~α~2~δ-1 subunits mediated by Nedd4-1 in biotinylation assays (*Biot.*) and in Western blot on whole-cell lysates (*WCL*). The number of independent experiments is indicated in *parentheses. A.U.*, arbitrary units. \*\*, *p* \< 0.01 and \*\*\*, *p* \< 0.001 when compared with control cells transfected with Ca~v~1.2α1/β~2~/α~2~δ-1 channels only.](zbc0151154360001){#F1}

Because Nedd4 ligases have been shown to promote the internalization of other ion channels ([@B5], [@B12], [@B15], [@B16]), we examined whether the decrease of Ca~v~ currents may be correlated to a decrease in the expression of Ca~v~ channels at the plasma membrane. We first performed immunocytochemistry experiments to examine the subcellular localization of Ca~v~1.2α1. The distribution pattern of Ca~v~1.2 channels was similar in control and Nedd4-1-transfected cells. As reported previously in other transfected cell lines ([@B4]), there was little or no clear accumulation of Ca~v~ channels at the plasma membrane of control cells ([supplemental Fig. 2](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). Nonetheless, we observed a reduction in the total fluorescence of 30 ± 9% in Nedd4-1-transfected cells compared with control, which hinted that this ubiquitin ligase may alter the overall expression of the channels. To quantify and compare the insertion of Ca~v~ channels in the two conditions, we used biochemistry techniques to measure the total expression and the membrane localization of the channels. We performed surface biotinylation assays, which detect only the proteins inserted in the plasma membrane. In control cells, transfected with the channels only, we were able to detect both Ca~v~1.2α1 and Ca~v~α~2~δ-1 subunits, as well as the cytosolic Ca~v~β~2~ ([Fig. 1](#F1){ref-type="fig"}*C*). This was expected as Ca~v~β subunits interact with Ca~v~1.2α1 and co-immunoprecipitate with this pore-forming subunit ([supplemental Fig. 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)) ([@B1], [@B2]). Another cytosolic protein, actin, which does not co-immunoprecipitate with Ca~v~ channels, was not detected in the surface biotinylated fraction, confirming that our protocol respected the integrity of the plasma membrane of the cells. We found that cells overexpressing Nedd4-1 showed a reduction in both the number of Ca~v~1.2 channels inserted at the plasma membrane ([Fig. 1](#F1){ref-type="fig"}, *C* and *E*) and in the total amount of channels expressed in the cells ([Fig. 1](#F1){ref-type="fig"}, *D* and *E*). Interestingly, both Ca~v~β~2~ and Ca~v~α~2~δ-1 were down-regulated in similar proportion as Ca~v~1.2α1 in cells overexpressing Nedd4-1 ([Fig. 1](#F1){ref-type="fig"}, *C--E*), indicating that Nedd4-1 regulates the whole channel complex rather than the sole pore-forming Ca~v~1.2α1. In agreement with its effect on Ca~v~ currents, the catalytically inactive Nedd4-1C867S increased both the total amount of Ca~v~1.2α1 subunits ([Fig. 1](#F1){ref-type="fig"}*D*) and their expression at the plasma membrane ([Fig. 1](#F1){ref-type="fig"}*C*). These findings suggest that the Nedd4-1-induced decrease of Ca~v~ current is caused by a reduction in the availability of channels at the plasma membrane rather than a functional inhibition of the channels.

#### Nedd4-1 Does Not Ubiquitylate Ca~v~1.2 Channels

We next examined whether Ca~v~1.2α1 was ubiquitylated by Nedd4-1. We assessed the ubiquitylation level of immunoprecipitated Ca~v~1.2α1 in Western blots, using FK2 antibodies that recognize polyubiquitylated proteins. We found that both native Ca~v~1.2α1 in cardiac lysate ([Fig. 2](#F2){ref-type="fig"}*A*) and Ca~v~1.2α1 expressed in HEK-293 cells ([Fig. 2](#F2){ref-type="fig"}, *B--D*) were ubiquitylated in basal conditions. In agreement with the Nedd4-1-induced reduction of Ca~v~1.2α1 shown in [Fig. 1](#F1){ref-type="fig"}*D*, the amount of immunoprecipitated Ca~v~1.2α1 ([Fig. 2](#F2){ref-type="fig"}*B*) was ∼45% smaller in HEK-293 cells co-transfected with Nedd4-1 *versus* the channels only. We compared the amount of ubiquitylated Ca~v~1.2α1, detected with the FK2 antibody, with the total amount of immunoprecipitated Ca~v~1.2α1 detected with the anti-Ca~v~1.2α1 antibody. This ratio, displayed in [Fig. 2](#F2){ref-type="fig"}*C*, shows that overexpressing Nedd4-1 failed to significantly increase the amount of ubiquitylated channels. Pulldown experiments performed using a GST-fused peptide corresponding to the protein S5A, which recognizes polyubiquitylated proteins ([@B17]), also failed to show any Nedd4-1-induced ubiquitylation of Ca~v~1.2α1 ([Fig. 2](#F2){ref-type="fig"}*C*). Likewise, the ubiquitylation level of Ca~v~1.2α1 was unchanged with the inactive mutant Nedd4-1C867S ([supplemental Fig. 3](http://www.jbc.org/cgi/content/full/M110.166520/DC1)).

![**The basal ubiquitylation of Ca~v~1.2α1 is not regulated by Nedd4-1.** *A*, native cardiac Ca~v~1.2α1 subunits were immunoprecipitated (*IP*) from mouse heart lysates, and their ubiquitylation state was determined by Western blotting (*WB*) with anti-ubiquitin FK2 antibodies. The *first lane* (−) shows a control experiment performed with unspecific rabbit antibodies. The *second lane* (+) shows the immunoprecipitated Ca~v~1.2α1. *B*, Western blots showing that Nedd4-1 reduced both the amount of immunoprecipitated Ca~v~1.2α1 and the corresponding FK2 signal in HEK-293 cells. *C*, ubiquitylated proteins were pulled down using ubiquitin binding GST-S5A. Western blots show that Nedd4-1 decreased the amount of Ca~v~1.2α1 in pulled down fractions and in whole-cell lysates. Bar graph shows the ratio of pulled down ubiquitylated Ca~v~1.2α1 *versus* total Ca~v~1.2α1, in five independent experiments. This ratio was calculated as the intensity of the smear containing several bands corresponding to ubiquitylated Ca~v~1.2α1 channels, divided by the intensity of the band corresponding to the total pool of Ca~v~1.2α1 subunits (ubiquitylated and nonubiquitylated) shown in the whole cell lysate. *D*, Western blots showing that the proteasome inhibitor MG132 (10 μ[m]{.smallcaps} for 8 h) antagonized the effect of Nedd4-1 and increased the amount of Ca~v~1.2α1 both in GST-S5A pulled down fractions and the corresponding whole-cell lysates. *NS*, not significant.](zbc0151154360002){#F2}

Kawaguchi *et al.* ([@B18]) had previously shown that ubiquitylation of Ca~v~1.2α1 was increased in the presence of the proteasome inhibitor MG132. Moreover, degradation of Ca~v~ channels by the proteasome has previously been reported ([@B19]). To make sure that a possible ubiquitylation by Nedd4-1 was not occulted by the concomitant degradation of the channels by the proteasome, we repeated GST-S5A pulldown experiments after treatment with MG132. As expected, the proteasome inhibitor increased the amount of ubiquitylated Ca~v~1.2 channels recovered in both control and Nedd4-1-transfected cells. Interestingly, MG132 also prevented the Nedd4-1-induced decrease of Ca~v~1.2α1 protein. However, and in agreement with our other results, Ca~v~1.2α1 were not further ubiquitylated by Nedd4-1 ([Fig. 2](#F2){ref-type="fig"}*D*).

Altogether, these results indicate that Ca~v~1.2α1 is not ubiquitylated by Nedd4-1. The effect of MG132 also suggests that proteasome-dependent degradation contribute to the inhibitory effect of Nedd4-1 on Ca~v~ channels.

#### Ca~v~β *Subunits Are Essential for Regulation of Ca~v~ Channels by Nedd4-1*

Because Ca~v~1.2α1 does not appear to be the direct target of Nedd4-1, we examined the possibility that Ca~v~ accessory subunits may be involved. The concentration of charge carrier (Barium) was increased to 20 m[m]{.smallcaps} to compensate for the reduced Ca~v~ trafficking observed in the absence of Ca~v~α~2~δ or Ca~v~β ([@B2], [@B3]). Whereas Ca~v~ channels expressed without Ca~v~α~2~δ were still sensitive to Nedd4-1 (−53 ± 13%; *n* = 14), those expressed without Ca~v~β failed to be regulated ([Fig. 3](#F3){ref-type="fig"}, *A* and *B*). Accordingly, neither the total amount ([Fig. 3](#F3){ref-type="fig"}*D*) nor the biotinylated fraction of Ca~v~ channels ([Fig. 3](#F3){ref-type="fig"}*C*) was affected by Nedd4-1 in the absence of Ca~v~β. [Fig. 3](#F3){ref-type="fig"}*E* shows that Ca~v~β~2~ subunits were ubiquitylated in control conditions; however, there was no further ubiquitylation with Nedd4-1. Likewise, Ca~v~α~2~δ-1, which are also ubiquitylated in basal conditions, were not further ubiquitylated by Nedd4-1 ([supplemental Fig. 4](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). Interestingly, all four isoforms (β~1~--β~4~) of Ca~v~β subunits supported the effect of Nedd4-1 on Ca~v~ currents ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)).

![**The effect of Nedd4-1 is Ca~v~β-dependent.** *A*, representative current traces. *B*, current-voltage relationships of Ca~v~1.2α1/Ca~v~α~2~δ-1 channels expressed without Ca~v~β in control and Nedd4-1-transfected cells. *C* and *D*, surface biotinylation assays were performed in cells transfected with Ca~v~1.2α1/Ca~v~α~2~δ-1 alone or together with Nedd4-1. Representative Western blots (*WB*) showing that Nedd4-1 did not affect the amount of Ca~v~1.2α1 and Ca~v~α~2~δ-1 subunits detected in the biotinylated fraction (*C*; *n* = 4) or corresponding whole-cell lysates (*D*; *n* = 4). *E*, anti-ubiquitin pulldown assays were performed in Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1-transfected cells. Western blots show that Nedd4-1 decreased the amount of Ca~v~β~2~ subunits in pulled down fractions and whole-cell lysates. Bar graph shows that the ratio of ubiquitylated Ca~v~β~2~ *versus* total Ca~v~β~2~ from four independent experiments. *NS*, not significant.](zbc0151154360003){#F3}

Hence, although they are not the direct target of Nedd4-1, Ca~v~β subunits are essential for the regulation of Ca~v~1.2 channels by Nedd4-1. Furthermore, the effect of Nedd4-1 is not Ca~v~β isoform-specific and may occur with any combination of Ca~v~β.

#### Nedd4-1 Does Not Promote Dynamin-dependent Ca~v~ Down-regulation

Ca~v~β subunits have been shown to bind to dynamin, a small GTPase involved in the formation of membrane vesicles, resulting in the internalisation of Ca~v~ channels inserted at the plasma membrane ([@B20]). We found that overexpressing dynamin alone was sufficient to decrease Ca~v~1.2α1/β~2~/α~2~δ-1 currents by 61 ± 15% (*n* = 10) ([Fig. 4](#F4){ref-type="fig"}*A*) but, as previously reported ([@B20]), there was no effect of dynamin on Ca~v~1.2α1/α~2~δ-1 channels lacking Ca~v~β ([Fig. 4](#F4){ref-type="fig"}*B*), confirming the essential role of Ca~v~β in the dynamin-dependent retrieval of Ca~v~ channels. In contrast, the catalytically inactive dynamin K44R, which cannot hydrolyze GTP and has been shown to interfere with the internalization of membrane proteins ([@B21]), did not significantly alter Ca~v~ current densities ([Fig. 4](#F4){ref-type="fig"}*C*), indicating that there is little or no constitutive down-regulation of Ca~v~ channels by endogenous dynamin in our model. In addition, Ca~v~ current densities were similar in cells transfected with dynamin K44R and Nedd4-1 *versus* Nedd4-1 alone ([Fig. 4](#F4){ref-type="fig"}*D*). The magnitude of the Nedd4-1-induced reduction in Ca~v~ current was also similar in the absence or presence of dynamin and reciprocally for the effect of dynamin in the absence or presence of Nedd4-1 ([Fig. 4](#F4){ref-type="fig"}, *C* and *D*). Therefore, although both Nedd4-1 and dynamin act through Ca~v~β subunits to regulate Ca~v~ channels, these two pathways are independent, and Nedd4-1 does not reduce Ca~v~ currents by promoting dynamin-dependent internalization of Ca~v~ channels.

![**Dynamin requires Ca~v~β to down-regulate Ca~v~ channels but is not involved in Nedd4-1-induced regulation.** *A* and *B*, representative whole-cell current traces in control and dynamin-transfected cells expressing Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 (*A*) and Ca~v~1.2α1/Ca~v~α~2~δ-1 (*B*) channels. *C* and *D*, effect of dynamin and dynamin K44R on Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 current densities in control (*white bars*) and Nedd4-1-transfected cells (*black bars*), recorded in 5 m[m]{.smallcaps} BaCl~2~ (*C*) or 20 m[m]{.smallcaps} BaCl~2~ (*D*). *NS*, not significant. *Error bars* are standard errors of the mean. \*, *p* \< 0.05, \*\*, *p* \< 0.01 when compared with cells not transfected with either dynamin constructs.](zbc0151154360004){#F4}

#### Nedd4-1 Prevents Targeting of Newly Synthesized Ca~v~ Channels to Plasma Membrane

Ca~v~β subunits have also been shown to promote the exit of Ca~v~α1 pore-forming subunits from the ER/Golgi ([@B22]). Therefore, we examined whether Nedd4-1 affected the forward trafficking of Ca~v~ channels. We used BFA, which impairs Golgi trafficking. 12 h of treatment with BFA was sufficient to significantly reduce Ca~v~ currents by 35 ± 25% (*n* = 8) in control cells ([Fig. 5](#F5){ref-type="fig"}*A*). After 24 h of BFA treatment, and despite a further 12-h expression, the amplitude of the residual Ca~v~ currents recorded in 5 m[m]{.smallcaps} BaCl~2~ was too small to reliably measure an effect of Nedd4-1([Fig. 5](#F5){ref-type="fig"}*A*); hence, we proceeded using 20 m[m]{.smallcaps} BaCl~2~. We found that the inhibitory effect of Nedd4-1 was no longer apparent when cells were treated with BFA (for 12 or 24 h; [Fig. 5](#F5){ref-type="fig"}*A*), suggesting that Nedd4-1 acts by interfering with the exit of Ca~v~ channels from the Golgi. This result was supported by surface biotinylation assays, which showed no significant change in the amount of Ca~v~1.2α1 channels inserted at the plasma membrane in BFA-treated cells ([Fig. 5](#F5){ref-type="fig"}*B*).

![**Nedd4-1 targets newly-synthesized Ca~v~ channels.** *A*, effect of BFA on Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 current densities in control (○) or Nedd4-1-transfected cells (●). Cells were incubated with BFA (50 ng/ml) 24 h post-transfection. \*, *p* \< 0.05 when compared with corresponding controls. *B*, representative Western blots (*WB*) showing that, upon treatment with BFA, Nedd4-1 did not affect the amount of Ca~v~1.2 channels detected in the biotinylated fraction (*n* = 3) or corresponding whole-cell lysates (*WCL*; *n* = 3). *C*, quantification is shown in the bar graph. *NS*, not significant; *Biot.*, biotinylated. The number of independent experiments is indicated in *parentheses. A.U.*, arbitrary units. *D*, lack of effect of Nedd4-1 on Ca~v~3.2α1/Ca~v~α~2~δ-1 current densities expressed without or with Ca~v~β~2~ subunits.](zbc0151154360005){#F5}

Recently, further roles have emerged for Ca~v~β subunits that may also act independently of Ca~v~ channels ([@B3]). To ensure that the Ca~v~β-dependent effect of Nedd4-1 was not due to an overall inhibition of membrane trafficking, we examined the effect of Nedd4-1 on Ca~v~3.2 T-type channels. Whether Ca~v~β interacts with Ca~v~3α1 subunit is still controversial ([@B1], [@B23]); however, it is generally accepted that Ca~v~3 channels do not require the co-expression of auxiliary subunits to be efficiently targeted to the plasma membrane ([@B23], [@B24]). In agreement with this, the amplitude of Ca~v~3.2 currents was similar in the absence or presence of Ca~v~β ([Fig. 5](#F5){ref-type="fig"}*C*). We found that Nedd4-1 did not affect the current densities of Ca~v~3.2 channels expressed either with or without Ca~v~β, indicating that trafficking of Ca~v~3.2 to the plasma membrane was not affected by the ubiquitin ligase. Additional experiments performed on cloned neuronal Ca~v~2.2 channels, which (like Ca~v~1.2) depend on Ca~v~β for efficient membrane targeting ([@B2]), showed that these channels are also regulated by Nedd4-1 ([supplemental Fig. 5](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). This result suggests that this regulation is not due to a specific interaction of Ca~v~β2 with Ca~v~1.2 and further highlights the broad physiological relevance of this regulation.

#### Nedd4-1 Targets Ca~v~ Channels for Degradation by Lysosome

The inhibitory effect of MG132, shown in [Fig. 2](#F2){ref-type="fig"}*D*, suggested that the proteasome was involved in Nedd4-1-induced degradation of Ca~v~ channels. To determine whether other degradation pathways were implicated, we pretreated the cells for 15 h (36 h post-transfection) with the lysosome inhibitor chloroquine. Chloroquine had no effect on basal Ca~v~ current densities; however, it partially prevented the effect of Nedd4-1 (by 45 ± 24%; *n* = 7; [Fig. 6](#F6){ref-type="fig"}*A*), suggesting that Nedd4-1 directs Ca~v~ channels for lysosomal degradation. The partial effect of chloroquine was consistent with an additional contribution of the proteasome.

![**Nedd4-1-induced regulation of Ca~v~ channels involves the lysosome.** *A*, effect of MDC (100 μ[m]{.smallcaps} for 15 h) and chloroquine (50 μ[m]{.smallcaps} for 15 h) on Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 current densities recorded in control (*white bars*) and Nedd4-1-transfected cells (*black bars*). †, *p* \< 0.05 when compared with Nedd4-1-transfected cells treated with vehicle only; \*, *p* \< 0.05 when compared with corresponding control cells. *B*, surface biotinylation assays were performed in control and Nedd4-1-transfected cells treated with MDC and chloroquine. Western blots (*WB*) and associated bar graph, in *C*, show that the treatment failed to prevent the down-regulation of Ca~v~1.2 channels in Nedd4-1-transfected cells. *A.U.*, arbitrary units. The number of independent experiments is indicated in *parentheses*. \*\*, *p* \< 0.01, \*\*\**p* \< 0.001 when compared with control cells transfected with Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1 channels only. *Biot.*, biotinylated; *WCL*, whole-cell lysate.](zbc0151154360006){#F6}

One way to transport cargo proteins from the TGN to other membrane compartments involves clathrin-coated post-Golgi carriers ([@B25]). To assess whether Nedd4-1 targeted Ca~v~ channels-containing post-Golgi carriers, we treated the cells with MDC, a drug that inhibits the formation of clathrin-coated pits ([@B26]). MDC was applied for 15 h, 36 h post-transfection. MDC did not significantly affect control Ca~v~ currents, suggesting that Ca~v~α1 channels are trafficked to the plasma membrane via clathrin-independent pathways. MDC partially antagonized the effect of Nedd4-1 on Ca~v~ currents (by 38 ± 17%; *n* = 8; [Fig. 6](#F6){ref-type="fig"}*A*). The extent of the inhibition produced by MDC was similar to the effect of chloroquine, and there was no additional effect when both drugs were added concomitantly (40 ± 19%; *n* = 8; [Fig. 6](#F6){ref-type="fig"}*A*), suggesting that these drugs inhibited a common pathway and that Nedd4-1 recruits clathrin-coated vesicles to transport Ca~v~α1 to the lysosome. This partial inhibition could not be seen on surface biotinylation and whole-cell lysate Western blots ([Fig. 6](#F6){ref-type="fig"}*B*). However, this could be attributed to the lack of sensitivity of the method. Most importantly, these experiments suggest that Nedd4-1 also induces the degradation of Ca~v~ channels via a lysosome-independent pathway, in agreement with the involvement of the proteasome suggested in [Fig. 2](#F2){ref-type="fig"}*D*.

#### Tyrosine 221 on Ca~v~β~2~ Subunit Is Required for Sorting of Ca~v~ Channels to Lysosome

We next investigated the role of Ca~v~β in this regulation. Because Ca~v~β is cytosolic, it is conceivable that they act as a bridge to enable interaction between Ca~v~α1 and the trafficking machinery. Several sorting signals for selection into clathrin-coated vesicles have been identified in the cytoplasmic tails of trans-membrane proteins. The best characterized is the YXXØ signal (Ø, bulky hydrophobic amino acid; X, any amino acid), which binds to the μ-subunits of the adaptor protein AP-1 ([@B27]). We identified a conserved YDVV motif in the SH3 domain of all four isoforms of Ca~v~β. Substitution of tyrosine 221 with an alanine in Ca~v~β~2~ (mutant Ca~v~β~2~Y221A) did not affect the basal current density ([Fig. 7](#F7){ref-type="fig"}*A*) nor the biophysical properties of Ca~v~ channels ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1); [Fig. 7](#F7){ref-type="fig"}*A*). However, the Y221A mutation partially reduced the effect of Nedd4-1 on Ca~v~ currents by 36%± 11 (*n* = 8) ([Fig. 7](#F7){ref-type="fig"}*A*). Most importantly, there was no further effect of chloroquine when Ca~v~ channels were expressed with Ca~v~β~2~Y221A instead of Ca~v~β~2~ ([Fig. 7](#F7){ref-type="fig"}*B*), confirming the involvement of this residue in the lysosome-dependent down-regulation of Ca~v~ channels.

![**Ca~v~β tyrosine 221 is involved in Nedd4-1-induced degradation of Ca~v~ channels by the lysosome.** *A*, current-voltage relationships showing the effect of Nedd4-1 on Ca~v~1.2α1/Ca~v~α~2~δ-1 channels expressed together with Ca~v~β~2~ or Ca~v~β~2~Y221A. Statistical analysis compared Ca~v~1.2α1/Ca~v~β~2~Y221A/Ca~v~α~2~δ-1/Nedd4-1 current densities with control cells (\*, *p* \< 0.05) and with Ca~v~1.2α1/Ca~v~β~2~/Ca~v~α~2~δ-1/Nedd4-1-transfected cells (†, *p* \< 0.05). *B*, Nedd4-1-transfected cells were treated with either vehicle (H~2~O) or chloroquine (50 μmol/liter) for 15 h at 37 °C. The bar graph shows that chloroquine had no significant (*NS*) effect on Ca~v~1.2α1/Ca~v~β~2~Y221A/Ca~v~α~2~δ-1 current densities.](zbc0151154360007){#F7}

DISCUSSION
==========

In this study, we uncovered a new Ca~v~β- and Nedd4-1-dependent mechanism controlling the sorting of newly synthesized Ca~v~ channels. Our data suggest that Nedd4 ubiquitin ligases promote the degradation of Ca~v~β-containing channels by both the proteasome and the lysosomes. Misfolded Ca~v~ channels have previously been reported to be degraded via endoplasmic reticulum-associated degradation ([@B19]). Most ubiquitin ligases involved in endoplasmic reticulum-associated degradation are yet to be identified ([@B5]), and one could suggest that endoplasmic reticulum-associated degradation account for the Nedd4-1-induced degradation of Ca~v~α1 by the proteasome. Nonetheless, this is unlikely to fully explain the effect of Nedd4-1 for three reasons: (i) the effect of Nedd4-1 is dependent on Ca~v~β, which associates with Ca~v~α1 at the exit of the ER ([@B22]), (ii) Nedd4-1 down-regulates both Ca~v~β and Ca~v~α~2~δ-1 together with Ca~v~1.2α1, and (iii) Nedd4-1 did not alter the proportion of Ca~v~β co-immunoprecipitated with Ca~v~1.2α1. These three points suggest that the Nedd4-1-regulated channels are correctly folded and processed beyond the ER until fully assembled at the exit of the TGN. Furthermore, we showed that treatment with either brefeldin A or chloroquine counteracted the effect of Nedd4-1 on Ca~v~ currents. Altogether, these data provide the first evidence that fully assembled Ca~v~ channels can be sorted directly from the TGN to the lysosome, without transiting to the plasma membrane. This finding is original because, to our knowledge, there is only one other example of such a regulation; in yeast, newly synthesized Gap1 ([g]{.ul}eneral [a]{.ul}mino acid [p]{.ul}ermease [1]{.ul}) is targeted to lysosomes instead of the plasma membrane ([@B6]), when the cell senses Gap1 is not required at the plasma membrane ([@B28]).

In contrast with Gap1 and other channels directly regulated by Nedd4, we found that Nedd4-1 does not ubiquitylate Ca~v~1.2α1 channels nor their associated subunits Ca~v~β~2~ and Ca~v~α~2~δ-1. Nonetheless, the increase in Ca~v~ current induced by Nedd4-1C867S ([Fig. 1](#F1){ref-type="fig"}) indicates that Nedd4-1 acts through its ubiquitin ligase activity. Interestingly, Nedd4 has previously been shown to indirectly regulate other proteins. For example, Myat *et al.* ([@B29]) have reported that *Drosophila* roundabout receptors were down-regulated upon ubiquitylation of their binding partner Commisureless by DNedd4, rather than by ubiquitylation of the receptor itself. In mammalian cells, Nedd4-1 has also been shown to promote the translocation of the lysosomal transmembrane protein LAPTM5 without ubiquitylating LAPTM5 ([@B30]). Instead, Nedd4-1 ubiquitylates Golgi-associated, γ-adaptin homologue, Arf-binding 3 (GGA3), which selects LAPTM5 at the TGN for translocation to the lysosomes, where LAPTM5 exerts its function. Likewise, Nedd4-1 may target signaling partners associated with the trafficking of Ca~v~ channels.

One important clue revealed by our study is the specific requirement of Ca~v~β subunits, which suggests Ca~v~β-interacting proteins as possible targets of Nedd4-1. Ca~v~β has been shown to interact with numerous proteins involved in signal transduction or protein trafficking. We tested the possible involvement of dynamin ([@B20]) which, like Nedd4-1, induces a Ca~v~β-dependent reduction in Ca~v~ currents. However, we found no evidence that Nedd4-1 either required or modified the interaction of dynamin with Ca~v~β. Ca~v~β subunits are also targeted by many signaling effectors, such as Akt serine/threonine kinases ([@B4]) and small G proteins ([@B31]). Akt promotes the insertion of Ca~v~ channels at the plasma membrane ([@B4]), whereas small G proteins of the RGK Ras-related family bind and sequestrate Ca~v~β subunits in the nucleus, preventing the surface expression of Ca~v~ channels ([@B31]). However, so far, there is no evidence suggesting a direct link between these candidates and Nedd4-1. We show that Ca~v~ currents are regulated by Nedd4-1 but not Nedd4-2 nor WWP2. Interestingly, it has recently been found that the μ1 subunit of AP-1 specifically interacts with Nedd4-1 and not Nedd4-2 nor WWP2, albeit the ubiquitylation of AP-1 itself has not been investigated ([@B32]). Furthermore, AP-1 has also been shown to interact with GGA1, -2, and -3 via their γ subunits ([@B33]), and GGA3 is an identified target of Nedd4-1 ([@B30]). Since the regulation of Ca~v~ channels is also specific to Nedd4-1 and because the clathrin inhibitor MDC partially antagonizes its effect on Ca~v~ currents, one attractive possibility is that the effect of Nedd4-1 may be mediated by the GGA-AP1 complex. One could speculate that ubiquitylation of GGA3 by Nedd4-1 may recruit Ca~v~ channels at the TGN, via their common interaction with AP-1. In support of this hypothesis, we provided preliminary data showing that the mutation of Ca~v~β on a putative μ1 binding motif prevented the lysosome-dependent down-regulation of Ca~v~ currents. Additional studies would be required to fully investigate this potential mechanism. The role of Ca~v~β in mediating the additional proteasome-dependent regulation of Ca~v~ channels by Nedd4-1 should also be further investigated.

Remarkably, the residual Ca~v~ channels that escaped Nedd4-1-induced degradation exhibited slightly different gating properties than in controls, depending on the isoform of Ca~v~β co-expressed with Ca~v~1.2α1 ([supplemental Table 1](http://www.jbc.org/cgi/content/full/M110.166520/DC1)). Phosphorylation of Ca~v~β has been shown to regulate Ca~v~ biophysical properties ([@B34], [@B35]). Hence, it is possible that Nedd4-1 modifies the gating of the channels by targeting one of the many kinases regulating Ca~v~β. It is also important to point out that Ca~v~β are composed of two main domains: a guanylate kinase domain and an SH3 domain, which promotes protein-protein interaction ([@B2], [@B3]). Changes in the interaction of the guanylate kinase and SH3 domains with each other, and with Ca~v~α1, have been shown to affect both the current-voltage relationship and steady-state inactivation of the channels ([@B3], [@B36]). Hence, the observed changes in gating properties may reflect the Nedd4-1-induced association of an intermediate partner binding the Ca~v~β SH3 and altering its interaction with Ca~v~1.2α1. In agreement with this hypothesis, the mutation Y221A on Ca~v~β~2~ SH3 domain antagonized the effect of Nedd4-1 both on whole-cell current densities and gating properties.

Nedd4-1 is expressed in many tissues ([@B8]), including the cardiovascular system. One role for Nedd4-1 may be to adjust Ca~v~1.2 channels availability at the membrane to meet the cellular demand. Ca~v~1.2 channels are responsible for the plateau of the action potential in ventricular cardiomyocytes ([@B37], [@B38], [@B39]), whereas in vascular smooth muscle cells, calcium entry via Ca~v~1.2 channels regulates vascular tone, making these channels a primary target for the treatment of cardiovascular diseases ([@B1]). It has been shown that Ca~v~ currents decrease in response to atrial fibrillation ([@B40]), and Ca~v~ density is reduced in cardiac hypertrophy ([@B41]); however, the underlying mechanisms are still unknown. Whether Nedd4-1 is involved in these adaptative mechanisms and how the action of Nedd4-1 on Ca~v~ channels may be regulated remain to be investigated.

Altogether, our results show that Nedd4-1 ubiquitin ligases control the availability of Ca~v~1.2 channels at the plasma membrane and reveal a new role for the Ca~v~β subunit, permitting Nedd4-1-dependent degradation of Ca~v~ channels at their exit from the ER/Golgi network.
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